정성원 (울산대학교 의과대학)님 | 한빛사연구자 > 한빛사

울산대학교 의과대학

최종업데이트 2024.08.05.

Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma
- Clin. Cancer Res., Feb 24 2025, | https://doi.org/10.1158/1078-0432.CCR-24-1228
- 2025-02
- 의약학
- 한빛사논문
Tenofovir is associated with a better prognosis than entecavir for hepatitis B virus-related hepatocellular carcinoma
- Clin. Gastroenterol. Hepatol., Jul 30 2024, S1542-3565(24)00684-0 | https://doi.org/10.1016/j.cgh.2024.07.013
- 2024-07
- 의약학
- 한빛사논문
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: A mendelian randomization and population-based cohort study
- Hepatology, Mar 11 2024, | https://doi.org/10.1097/HEP.0000000000000837
- 2024-03
- 의약학
- 한빛사논문
Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study
- EClinicalMedicine, Nov 2023, 65 102300 | https://doi.org/10.1016/j.eclinm.2023.102300
- 2023-11
- 의약학
- 한빛사논문
Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study
- J. Clin. Oncol., Published online May 13, 2022 | DOI: 10.1200/JCO.21.01285
- 2022-05
- 의약학
- 한빛사논문

연구자 ID

저자논문